142 results on '"Marchei E"'
Search Results
2. Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject
- Author
-
Marchei, E., Farrè, M., Pellegrini, M., García-Algar, Ó., Vall, O., Pacifici, R., and Pichini, S.
- Published
- 2010
- Full Text
- View/download PDF
3. Clinical features and risk factors associated with prenatal exposure to drugs of abuse [Características clínicas y factores de riesgo asociados a la exposición prenatal a drogas de abuso]
- Author
-
Roca, A., Jarque, P., Gomila, I., Marchei, E., Tittarelli, R., Elorza, M. A., Sanchis, P., and Barcelo, B.
- Subjects
biomarkers ,meconium ,neonatal intensive care unit ,prenatal exposure - Published
- 2021
4. On-site screening and GC–MS analysis of cocaine and heroin metabolites in body-packers urine
- Author
-
Marchei, E., Colone, P., Nastasi, G.G., Calabrò, C., Pellegrini, M., Pacifici, R., Zuccaro, P., and Pichini, S.
- Published
- 2008
- Full Text
- View/download PDF
5. Development and validation of a liquid chromatography–mass spectrometry assay for hair analysis of methylphenidate
- Author
-
Marchei, E., Muñoz, J.A., García-Algar, Ó., Pellegrini, M., Vall, O., Zuccaro, P., and Pichini, S.
- Published
- 2008
- Full Text
- View/download PDF
6. Targeted screening and quantification of synthetic cathinones and metabolites in hair by UHPLC-HRMS.
- Author
-
LA MAIDA, N., MANNOCCHI, G., PICHINI, S., BASILE, G., DI GIORGI, A., BUSARDÒ, F. P., and MARCHEI, E.
- Abstract
OBJECTIVE: Synthetic cathinones (SCs) are new psychoactive substances with sympathomimetic effects, which emerged into the illegal drug market to replace controlled stimulants. Since every year more powerful and toxic substances enter the illicit market, there is the need for analytical methodologies able to detect these new compounds in conventional and non-conventional biological matrices. We sought to develop and validate a targeted screening and quantification method for thirty-two parent SCs and two metabolites in hair samples by ultra-high-performance liquid chromatography coupled to high resolution mass spectrometry (UHPLC-HRMS). MATERIALS AND METHODS: 20 mg hair samples were soaked in 250 µL of 2 mM ammonium formate, methanol and acetonitrile mixture (50/25/25, v/v/v) and incubated overnight at 40°C. After incubation, the samples were evaporated to dryness under nitrogen stream and reconstituted with 100 µL of mobile phase mix (A:B, 80:20) and 10 µL were injected into UHPLC-HRMS. A Q ExactiveTM Focus Orbitrap Mass spectrometer with full scan and targeted data-dependent MS/MS scan acquisition was used for the screening and quantitation analysis. RESULTS: The assay was linear from 5 to 500 pg/mg hair for all the analytes under investigation. Intra-day and inter-day precision were always < 15% and matrix effect and analytical recovery were always within acceptable criteria (±25% and >50%, respectively). The developed method was applied to authentic hair samples from SCs consumers. The most prevalent found SCs were 3,4-Methylenedioxy-a-Pyrrolidinohexanophenone with a concentration range of 6.0-1,000.0 pg/mg along with a-Pyrrolidinohexiophenone (54.0 and 554.0 pg/mg, respectively), 3-Methylmetcathinone (556.0 and 5,000.0 pg/mg) and 4-Methylethcathinone (11.5 and 448.0 pg/mg). CONCLUSIONS: The developed method showed good selectivity, specificity, an easy and low-cost sample preparation and an analysis time compatible with a high throughput laboratory. [ABSTRACT FROM AUTHOR]
- Published
- 2022
7. New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity
- Author
-
Carafa, M, Marianecci, C, Lucania, G, Marchei, E, and Santucci, E
- Published
- 2004
- Full Text
- View/download PDF
8. Development and validation of a liquid chromatography–mass spectrometry assay for the determination of opiates and cocaine in meconium
- Author
-
Pichini, S, Pacifici, R, Pellegrini, M, Marchei, E, Pérez-Alarcón, E, Puig, C, Vall, O, and Garcı́a-Algar, O
- Published
- 2003
- Full Text
- View/download PDF
9. Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy
- Author
-
Gómez-Roig MD, Marchei E, Sabra S, Busardò FP, Mastrobattista L, Pichini S, and Gratacós E
- Subjects
Drinking behavior ,Hair testing ,integumentary system ,otorhinolaryngologic diseases ,Pregnancy ,Smoking habit ,sense organs ,Ethyl glucuronide ,Nicotine - Abstract
This study aimed to objectively verify smoking and drinking behavior during pregnancy and to disclose self-misreporting through maternal hair analysis. A total of 153 women attending a university hospital in Barcelona (Spain) were selected and interviewed after delivery, on their smoking and drinking habits during pregnancy. A 9-cm hair strand was collected and analyzed by liquid chromatography tandem mass spectrometry for the presence of nicotine (NIC) and ethyl glucuronide (EtG) as biomarkers of tobacco and alcohol consumption, respectively. Concentrations of EtG
- Published
- 2018
10. Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of antidepressant and anxiolytic drugs in neonatal meconium and maternal hair
- Author
-
Pichini S, Cortes L, Marchei E, Solimini R, Pacifici R, Gómez-Roig MD, and García-Algar O
- Published
- 2016
11. Assessment of prenatal exposure to ethanol by meconium analysis: results of an Italian multicenter study
- Author
-
Pichini S, Marchei E, Vagnarelli F, Tarani L, Maffucci R, Sacher B, Bisceglia M, Rapisardi G, Elicio MR, Biban P, Zuccaro P, Pacifici R, Pierantozzi A, Morini L., RAIMONDI, FRANCESCO, Pichini, S, Marchei, E, Vagnarelli, F, Tarani, L, Raimondi, Francesco, Maffucci, R, Sacher, B, Bisceglia, M, Rapisardi, G, Elicio, Mr, Biban, P, Zuccaro, P, Pacifici, R, Pierantozzi, A, and Morini, L.
- Published
- 2012
12. Pharmacokinetiks of Atomoxetine in plasma and oral fluid in pediatric patients with attention deficit/hyperactivity disorder
- Author
-
Papaseit, E., primary, Garcia-Algar, O., additional, Aznar, G., additional, Marchei, E., additional, Pacifici, R., additional, Pichini, S., additional, and Farré, M., additional
- Published
- 2015
- Full Text
- View/download PDF
13. Is GHB-glucuronide useful as a biomarker for the exogenous use of GHB?
- Author
-
Marchei, E., Tini, A., Pirani, F., Lo Faro, A. F., and Marinelli, S.
- Abstract
The article offers information on the importance of gamma-hydroxybutyric acid (GHB) detection in biological matrices of unconscious and conscious consumers in many forensic and clinical settings because of its recreational use purposes in 2019. The primary issue in the analytical determination of GHB concentrations in keratin matrices and biological fluids derives from the significance to be able to identify endogenous GHB of an illegal drug from exogenous administration.
- Published
- 2019
14. PO-0590 Substance Abuse Determination In Alternative Matrices Of Breastmilk Donors
- Author
-
García-Lara, N, primary, Escuder-Vieco, D, additional, García-Algar, O, additional, Marchei, E, additional, Pichini, S, additional, and Pallás-Alonso, CR, additional
- Published
- 2014
- Full Text
- View/download PDF
15. O19: Identification and quantification of THC-COOH glucuronide in hair by ultra-performance liquid chromatography tandem mass spectrometry
- Author
-
Pichini, S., primary, Martello, S., additional, Gottardi, M., additional, Marchei, E., additional, Pellegrini, M., additional, Svaizer, F., additional, Lotti, A., additional, Pacifici, R., additional, and Chiarotti, M., additional
- Published
- 2014
- Full Text
- View/download PDF
16. Nuove vescicole non fosfolipidiche: effetto della presenza di tensioattivi ionici nella formulazione
- Author
-
Santucci, Eleonora, Carafa, Maria, Marchei, E., Alhaique, Franco, Coviello, Tommasina, Murtas, Evelina, and Riccieri, Fulvio Maria
- Published
- 1998
17. A study on the interaction of surfactant vesicles (SVs) with liposomes and human cells
- Author
-
Carafa, Maria, Santucci, Eleonora, Marchei, E., Riccieri, Fulvio Maria, Lucania, Giuseppe, Torrisi, M. R., and Pavan, A.
- Published
- 1998
18. Nuove vescicole non fosfolipidiche: rilascio in vitro di farmaci modello
- Author
-
Carafa, Maria, Santucci, Eleonora, Marchei, E, Alhaique, Franco, Coviello, Tommasina, Murtas, Evelina, and Riccieri, F. M.
- Published
- 1998
19. The digitized archive of the Arcetri spectroheliograms. Preliminary results from the analysis of Ca II K images
- Author
-
Ermolli, I., primary, Marchei, E., additional, Centrone, M., additional, Criscuoli, S., additional, Giorgi, F., additional, and Perna, C., additional
- Published
- 2009
- Full Text
- View/download PDF
20. Application of a validated high-performance liquid chromatography–mass spectrometry assay to the analysis of - and -hydroxybenzoylecgonine in meconium
- Author
-
PICHINI, S, primary, MARCHEI, E, additional, PACIFICI, R, additional, PELLEGRINI, M, additional, LOZANO, J, additional, and GARCIAALGAR, O, additional
- Published
- 2005
- Full Text
- View/download PDF
21. P.5.028 Estimates of illicit drug use during pregnancy by maternal interview and meconium analysis
- Author
-
Mortali, C., primary, Marchei, E., additional, Pellegrini, M., additional, Perez-Alarcòn, E., additional, Puig, C., additional, Vall, O., additional, Pacifici, R., additional, Ordobas, L., additional, Pachini, S., additional, and Garcia-Algar, O., additional
- Published
- 2003
- Full Text
- View/download PDF
22. Application of a validated high-performance liquid chromatography–mass spectrometry assay to the analysis of m- and p-hydroxybenzoylecgonine in meconium
- Author
-
Pichini, S., Marchei, E., Pacifici, R., Pellegrini, M., Lozano, Jaime, and García-Algar, O.
- Published
- 2005
- Full Text
- View/download PDF
23. Assay of g-glutamylcysteine synthetase activity in Plasmodium berghei by liquid chromatography with electrochemical detection
- Author
-
Birago, C., Marchei, E., Pennino, R., and Valvo, L.
- Published
- 2001
- Full Text
- View/download PDF
24. Ethylglucuronide and ethylsulfate in meconium to assess gestational ethanol exposure: Preliminary results in two mediterranean cohorts
- Author
-
Pichini, S., Morini, L., Marchei, E., Palmi, I., maria concetta rotolo, Vagnarelli, F., Garcia-Algar, O., Vall, O., and Zuccaro, P.
25. Liquid chromatography-mass tandem spectrometry assay (LC-MS/MS) for licit and illicit drugs in breast milk | Determinazione di sostanze farmacologicamente attive lecite e illecite nel latte materno mediante cromatografia liquida - Spettrometria di massa tandem
- Author
-
Marchei, E., Pellegrini, M., maria concetta rotolo, Palmi, I., Garcia-Algar, O., Escuder, D., Pallas, C. R., Pichini, S., and Pacifici, R.
26. The prevalence and changes of alcohol consumption across three trimesters of pregnancy assessed by ethyl glucuronide concentration in maternal hair and self-reports: a cross-sectional study.
- Author
-
Okulicz-Kozaryn K, Marchei E, Helwich E, Rutkowska M, Maciejewski TM, Gumuła P, Januszaniec-Piotrowska A, Bójko M, Radiukiewicz K, Dzielska A, and Pichini S
- Abstract
Introduction: The teratogenic effect of alcohol is well known, but its prevalence is usually underestimated. This study presents the findings of a cross-sectional study conducted in Poland, which aimed to assess the prevalence and changes in alcohol consumption during pregnancy. The study utilized ethyl glucuronide concentration in maternal hair and self-reports as measures to evaluate alcohol intake across the three trimesters of pregnancy., Methods: The study involved postpartum women (n=150) and their babies. Hair samples from 135 participants allowed segmental analysis (separately for the three trimesters) and hair from 15 were analysed for the entire 9 moths by gas chromatography tandem mass spectrometry. Survey data included self-reports of health related behaviours and socio-demographic characteristics; medical records - information on the course of a pregnancy and newborns health., Results: Standard medical interview revealed no cases of alcohol use during pregnancy. The analysis of EtG indicated 50.3% women had been drinking alcohol at any time during pregnancy, including 10% with excessive alcohol consumption. Most participants maintained the same level of alcohol consumption throughout the pregnancy but 8.7% women decreased and 20.7% increased the amount of alcohol consumed between 1st and 2nd or 2nd and 3rd trimester. Gestational consumption of alcohol was not related to sociodemographic characteristics, course of pregnancy and self-reported health behaviours but babies of women who drunk alcohol during pregnancy were more often small for gestation age than babies of abstainers (OR=6.008), with the highest risk observed in case of increased alcohol consumption (OR=12,348)., Conclusions: Maternal hair analysis is useful in detecting pregnancy alcohol use and allows retrospective analysis over a longer period than other biological samples, providing a more comprehensive pattern of use throughout pregnancy. However, there is a need to improve routine methods of interviewing patients about alcohol use and to implement effective preventive strategies regarding alcohol consumption during pregnancy in Poland., (S. Karger AG, Basel.)
- Published
- 2024
- Full Text
- View/download PDF
27. Prevalence of Psychoactive Substance Use During Pregnancy in Argentine Women: A Pilot Study Testing Maternal Hair.
- Author
-
Vieiros M, Mirahi A, Villarreal M, Ramos-Triguero A, Fernández-Rubal I, Andreu-Fernández V, Pichini S, García-Algar Ó, and Marchei E
- Subjects
- Humans, Female, Pregnancy, Argentina epidemiology, Pilot Projects, Adult, Cross-Sectional Studies, Prevalence, Young Adult, Alcohol Drinking epidemiology, Pregnancy Complications epidemiology, Substance-Related Disorders epidemiology, Hair chemistry, Psychotropic Drugs analysis, Substance Abuse Detection methods
- Abstract
Background: The use of psychoactive substances (PSs) during pregnancy is a major public health concern because of their increasing prevalence worldwide. This study examined the understudied issue of gestational PS consumption in a cohort of Argentine delivering mothers., Methods: A cross-sectional pilot study involving 51 women receiving delivery care was conducted at the Santa Rosa Hospital in La Pampa, Argentina. Information on maternal sociodemographic characteristics, pregnancy history, and drug use was obtained through standardized interviews. Maternal hair samples were analyzed for alcohol, tobacco, licit, illicit, and prescription substance biomarkers using ultra-high-performance liquid chromatography high-resolution mass spectrometry and gas chromatography mass spectrometry., Results: During pregnancy, 49.0% of participants reported alcohol consumption, 25.5% reported tobacco use, and 23.5% reported cannabis use. Hair samples from 56.9% of the women were positive for illicit PSs, with the most frequent being cocaine (41.2%) and cannabis (15.7%). Among the women, 47.1% consumed alcohol during pregnancy. Of the 24 women with hair ethyl glucuronide ≥5 pg/mg, 33.3% drank until the end of gestation and 58.3% started a social drinking habit in the second half. The analysis also detected prescription substances (anticonvulsants, antidepressants, methadone, opioids, antihistamines, antiemetics, and analgesics), caffeine (70.6%), lidocaine, and levamisole, some of which were cocaine or opioid adulterants., Conclusions: This is the first study to objectively assess the consumption of licit and illicit PSs during pregnancy in Argentina. In contrast to most nearby countries, cocaine was the most detected illicit PS in this cohort of Argentine delivering women. This finding highlights the importance of regular monitoring of local trends in PS use during pregnancy., Competing Interests: The authors declare no conflict of interest., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. NPS-EQA PART I: Four years' experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in oral fluid.
- Author
-
Marchei E, Graziano S, Varì MR, Minutillo A, Aquilina V, Pichini S, and Rotolo MC
- Subjects
- Central Nervous System Agents, Italy, Tryptamines, Cocaine analysis, Cannabinoids analysis
- Abstract
In 2019, Italian National Institute of Health established an external quality assessment program (EQA) to evaluate the performance of oral fluid testing for classical and new psychoactive substances by laboratories participating in the National Early Warning System collaborative centres. This report presents the results of four rounds between 2019 and 2023. Eleven oral fluid specimens, including 3 blank samples, were prepared by adding different classes of and new psychoactive drugs at known concentrations to pre-screened drug-free oral fluid. False-negative and false-positive results were calculated for the qualitative data evaluation. The quantitative evaluation measured the imprecision and accuracy of the results, in terms of coefficient of variation (CV%) and percent error (ERR%), respectively, with respect to a mean value obtained by reference laboratories. Z-score values were then calculated. Over the years, there has been a significant improvement in false-negative results (from 42.7% in the first year to 19.4% in the last year), but not in false-positive results (from 33.3% in the first year to 22.2% in the last one). In addition to the classic drugs of abuse (e.g. cocaine, amphetamine, methadone), the substances found in false positive samples belonged to the class of synthetic cannabinoids (e.g 5-fluoro CUMYL-PINACA and 5-fluoro-EDMB-PICA), synthetic opioids (e.g butyrylfentanyl) and tryptamines (e.g. 5-methoxy-N-methyl-N-isopropyltryptamine). The four rounds yielded a mean ERR% of approximately 22.1% and a mean CV% of around 41.5%. The participating laboratories demonstrated variable performances in relation to the class of analysed psychoactive substances, as evidenced by the calculated Z-scores. Between 25% and 60% of the reported results in all rounds should be considered satisfactory. EQA is a crucial element of laboratory quality management systems. It promotes continuous improvement and maintains high standards in the field of forensic and clinical drug testing., Competing Interests: Declaration of Competing Interest all the authors have no competing interests to declare., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. NPS-EQA PART II: Four years' experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in hair.
- Author
-
Rotolo MC, Graziano S, Varì MR, Minutillo A, Di Giorgi A, Aquilina V, Pichini S, and Marchei E
- Subjects
- Italy, Central Nervous System Agents, Hair
- Abstract
In 2019, the Italian National Institute of Health established an external quality assessment (EQA) program to evaluate the performance of laboratories of collaborative centres participating in the National Early Warning System in hair testing for classical and new psychoactive substances (NPS). The results obtained in the four rounds (2019-2023) and the evolution in hair testing performance for classic drugs of abuse and new psychoactive substances are presented. A total of 11 hair specimens, including 3 blank samples, were prepared by adding different classes of classical and NPS at known concentrations to pre-screened drug-free hair. False negative and false positive results were calculated for the qualitative data evaluation. The quantitative evaluation included the imprecision (as % coefficient of variation, CV%) and the accuracy (as % error, ERR%) of the results with respect to a mean value obtained by reference laboratories and Z-score values were assessed. Over the years, an improvement in false negative results (from 52.4% in the first year to 34.3% in the last one) and false positive results (from 55.0% in the first year to 30.8.% in the last one) was observed. In the first round, the mean ERR% ranged from 6.2% to 112.8% due to NPS determination. However, in the subsequent three rounds, the mean ERR% ranged from 10.4% to 22.4%, The mean CV% in the four rounds was approximately 41.5% (ranging from 44.3% to 53.3%). Between 12.0% and 56.6% of the reported results in all rounds should be considered satisfactory. EQA programs help laboratories to identify and correct problems within their processes by highlighting errors and variations. This ensures that the results produced are accurate and reproducible., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
30. OILVEQ: an Italian external quality control scheme for cannabinoids analysis in galenic preparations of cannabis oil.
- Author
-
Rotolo MC, Graziano S, Minutillo A, Varì MR, Pichini S, and Marchei E
- Subjects
- Italy, Dronabinol analysis, Dronabinol analogs & derivatives, Humans, Plant Oils analysis, Plant Oils chemistry, Plant Oils standards, Cannabis chemistry, Cannabidiol analysis, Gas Chromatography-Mass Spectrometry standards, Reproducibility of Results, Cannabinoids analysis, Cannabinoids standards, Quality Control
- Abstract
Objectives: Italy legalized cannabis oil for specific medical conditions (neuropathic pain, refractory epilepsy and other established pathologies) in 2015, but mandates titration of principal cannabinoids before marketing each batch using iphenated techniques coupled with mass spectrometry. To assess reliability of laboratories from the Italian National Health Service in charge of titrating the batches, the Italian National Institute of Health set up an quality control program on determination of Δ9-tetrahydrocannabinol l (THC), cannabidiol (CBD), Δ9-tetrahydrocannabinolic acid A (THCA-A) and cannabidiolic acid (CBDA) in cannabis oil preparations., Methods: Two rounds of exercises have been carried out since 2019, involving sixteen Italian laboratories. Five different cannabis oil samples (19-1A and 19-1B for the first round and 22-1A, 22-1B and 22-1C for the second one were prepared and 1 mL amount of each sample was sent to the laboratories. The quantitative performance of each laboratory was assessed calculating the Z-score value, a statistical measurement for value's relationship to the mean of a group of values., Results: In the first round, eight out of fourteen laboratories employed an LC-MS while the remaining six used GC-MS. Differently, in the second round, six out of eleven laboratories employed a GC-MS while the remaining five used LC-MS. In the first round, only 28.6 % laboratories achieved an acceptable performance (Z-score±2), and all of them used LC-MS as analytical method. In the second round, none of the laboratories achieved an acceptable performance. Satisfactory results, based on Z-scores, were generally low (0.0-75.0 %), with only one exception of 100 % for THCA-A determination in sample 22-1B. In the second round, three false negatives (two THC and one CBD by GC-MS determination) were reported while no false positives were described in the blank sample. The two rounds yielded a mean ERR% of 42 % approximately and a mean CV% around 70 % in GC-MS determination. When applying LC-MS determination, the two rounds yielded a mean ERR% of 36 % approximately and a mean CV% around 33 %., Conclusions: The obtained results underline the need for a clear and consistent protocol to be adopted by all laboratories intending to include the titration of oily cannabis-based products into their routinely analytical techniques. This emphasis on methodology standardization and participation to quality control schemes is essential for ensuring reliable and accurate measurements, ultimately enhancing the overall effectiveness and reliability of medical cannabis treatments., (© 2024 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2024
- Full Text
- View/download PDF
31. Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS.
- Author
-
Massano M, Nuñez-Montero M, Papaseit E, Hladun O, Pérez-Maña C, Ventura M, Marchei E, Alladio E, Gerace E, Pichini S, Farrè M, and Salomone A
- Subjects
- Humans, Chromatography, High Pressure Liquid, Reproducibility of Results, Metabolome, Synthetic Cathinone, Glucuronides, Methylamines, Propiophenones
- Abstract
Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption. In this context, we investigated their metabolic profile using of UHPLC-QTOF-HRMS to elucidate the distribution of the parent drug and its metabolites in urine samples over time. Initially, both male and female volunteers were divided into three groups and eight subjects of each group were administered intranasally or orally with one SC (20-40 mg of NEH or NEP intranasal, 100-150 mg of 4-CMC oral). Urine samples were collected at 0-2 and 2-4 or 2-5 h. Urine (50 μL) was diluted 1:2 with acetonitrile/methanol (95:5) and injected into the UHPLC-QTOF-HRMS. Phase-I and phase-II metabolites were identified on the basis of fragmentation patterns and exact masses. Several phase-I and glucuronide-phase-II metabolites were identified in urine samples. Keto group reduction, hydroxylation and dealkylation were the common metabolic pathways identified for all cathinones and the presence of NEH-glucuronide, NEP-glucuronide and 4-CMC-glucuronide was also relevant. Significant is the slower metabolite formation for 4-CMC, which was detected at high concentrations in its original form even 5 h after administration, due to its long half-life and low intrinsic clearance compared to the other SCs. UHPLC-QTOF-HRMS demonstrated a considerable capability to semi-quantify the three synthetic cathinones and identify the target metabolites with high reliability. The introduction of new target compounds improves the efficiency of toxicological screening analysis on real samples and extends the window of detection of the SCs in biological matrices., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
32. Alcohol Consumption Assessed by a Biomarker and Self-Reported Drinking in a Sample of Pregnant Women in the South of Europe: A Comparative Study.
- Author
-
Corrales-Gutierrez I, Gomez-Baya D, Leon-Larios F, Medero-Canela R, Marchei E, Mendoza-Berjano R, and García-Algar Ó
- Abstract
(1) Background: Alcohol consumption during pregnancy is a major concern, particularly in Europe and North America. Its prevalence has so far been under-researched. In most studies, the determination of this consumption may be underestimated, as it is based on the information obtained from questionnaires rather than from biomarkers, which will provide a much more reliable approach. The main objective of this study was to compare the prevalence of consumption during pregnancy as assessed by a questionnaire and a hair biomarker. (2) Method: A cross-sectional study with a random sample of 425 pregnant women treated in public hospital consultations in Seville (Spain) and in the 20th week of their pregnancy, orally interviewed using an elaborated ad hoc questionnaire that evaluated variables of sociodemographic, obstetric, and alcohol consumption. Furthermore, the ethyl glucuronide metabolite (EtG) was tested on a hair sample in 252 pregnant women who agreed to facilitate it. Once the data obtained through the questionnaire and hair test were analyzed, the level of metabolites and self-reported alcohol consumption were compared. (3) Results: The prevalence of self-reported alcohol consumption (questionnaire) was 20.7%, and the real consumption (metabolite analysis) was 20.2%. In 16.8% of pregnant women who declared not consuming alcohol during their pregnancy, noticeable consumption was detected according to the metabolite test. No relevant level of variability in estimated alcohol consumption was detected in the biomarker with respect to the sociodemographic and obstetric variables studied. (4) Conclusions: The prevalence of alcohol consumption during pregnancy obtained through both questionnaires and metabolite analyses was similar and high. There is no association between consumption and sociodemographic factors in this sample. The determination of consumption through biomarkers allows for a more accurate approximation of the prevalence of consumption than estimated through questionnaires. Larger sample-sized studies are needed to determine consumption patterns and thus guide the adoption of more precise policies fostering abstinence from alcohol consumption since the preconception period.
- Published
- 2023
- Full Text
- View/download PDF
33. Assessment of alcohol consumption in mexican pregnant women by hair testing of ethyl glucuronide.
- Author
-
Marchei E, Gomez-Ruiz LM, Acosta-López A, Ramos-Gutiérrez RY, Varela-Busaka MB, Lombroni C, Andreu-Fernandez V, Pichini S, and Garcia-Algar O
- Subjects
- Humans, Female, Pregnancy, Mexico epidemiology, Alcohol Drinking epidemiology, Glucuronates analysis, Ethanol analysis, Hair chemistry, Biomarkers analysis, Pregnant Women, Tandem Mass Spectrometry methods
- Abstract
There are no studies that have utilized both biomarkers and self-reported data to evaluate maternal alcohol use during pregnancy in Mexico. Therefore, we aimed to describe the prevalence of alcohol consumption in a cohort of 300 Mexican pregnant women. We used a validated ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method to measure hair ethyl glucuronide (EtG) in hair segments that corresponded to the first and second half of pregnancy. We compared the hair EtG values to a self-reported questionnaire on maternal drinking habits and evaluated whether the gestational alcohol use was associated with psychotropic drug use. Based on the EtG measurements, 263 women (87.7%) were alcohol-abstinent during the entire pregnancy, while 37 (12.3%) had used alcohol at least once during the pregnancy. Of these, only two women were found to have problematic alcoholic behavior during the entire pregnancy. No significant differences in sociodemographic characteristics were observed between alcohol-abstinent women and women with drinking habits. The self-reporting data and hair EtG gave heterogeneous results: although 37 women had self-reported alcohol use during pregnancy, only 54.1% of these women tested positive for hair EtG. Of the women who tested positive for hair EtG, 54.1% tested positive for psychoactive substances. In our cohort, the use of drugs of abuse was independent of gestational drinking. This study provided the first objective evidence of prenatal ethanol consumption in a cohort of Mexican pregnant women., Competing Interests: Declaration of competing interest None to disclose., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
34. The recurrent pathogenic Pro890Leu substitution in CLTC causes a generalized defect in synaptic transmission in Caenorhabditis elegans .
- Author
-
Pannone L, Muto V, Nardecchia F, Di Rocco M, Marchei E, Tosato F, Petrini S, Onorato G, Lanza E, Bertuccini L, Manti F, Folli V, Galosi S, Di Schiavi E, Leuzzi V, Tartaglia M, and Martinelli S
- Abstract
De novo CLTC mutations underlie a spectrum of early-onset neurodevelopmental phenotypes having developmental delay/intellectual disability (ID), epilepsy, and movement disorders (MD) as major clinical features. CLTC encodes the widely expressed heavy polypeptide of clathrin, a major component of the coated vesicles mediating endocytosis, intracellular trafficking, and synaptic vesicle recycling. The underlying pathogenic mechanism is largely unknown. Here, we assessed the functional impact of the recurrent c.2669C > T (p.P890L) substitution, which is associated with a relatively mild ID/MD phenotype. Primary fibroblasts endogenously expressing the mutated protein show reduced transferrin uptake compared to fibroblast lines obtained from three unrelated healthy donors, suggesting defective clathrin-mediated endocytosis. In vitro studies also reveal a block in cell cycle transition from G0/G1 to the S phase in patient's cells compared to control cells. To demonstrate the causative role of the p.P890L substitution, the pathogenic missense change was introduced at the orthologous position of the Caenorhabditis elegans gene, chc-1 (p.P892L), via CRISPR/Cas9. The resulting homozygous gene-edited strain displays resistance to aldicarb and hypersensitivity to PTZ, indicating defective release of acetylcholine and GABA by ventral cord motor neurons. Consistently, mutant animals show synaptic vesicle depletion at the sublateral nerve cords, and slightly defective dopamine signaling, highlighting a generalized deficit in synaptic transmission. This defective release of neurotransmitters is associated with their secondary accumulation at the presynaptic membrane. Automated analysis of C. elegans locomotion indicates that chc-1 mutants move slower than their isogenic controls and display defective synaptic plasticity. Phenotypic profiling of chc-1 (+/P892L) heterozygous animals and transgenic overexpression experiments document a mild dominant-negative behavior for the mutant allele. Finally, a more severe phenotype resembling that of chc-1 null mutants is observed in animals harboring the c.3146 T > C substitution (p.L1049P), homologs of the pathogenic c.3140 T > C (p.L1047P) change associated with a severe epileptic phenotype. Overall, our findings provide novel insights into disease mechanisms and genotype-phenotype correlations of CLTC -related disorders., Competing Interests: EL and VF were employed by D-Tails s.r.l. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Pannone, Muto, Nardecchia, Di Rocco, Marchei, Tosato, Petrini, Onorato, Lanza, Bertuccini, Manti, Folli, Galosi, Di Schiavi, Leuzzi, Tartaglia and Martinelli.)
- Published
- 2023
- Full Text
- View/download PDF
35. GC-MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study.
- Author
-
Nuñez-Montero M, Lombroni C, Maida N, Rotolo MC, Pichini S, Papaseit E, Hladun O, Ventura M, Poyatos L, Pérez-Mañá C, Farré M, and Marchei E
- Subjects
- Humans, Gas Chromatography-Mass Spectrometry methods, Pilot Projects, Sweat, Tandem Mass Spectrometry methods, Synthetic Cathinone
- Abstract
This study presents a validated GC-MS/MS method for the detection and quantification of 4-chloromethcathinone or clephedrone (4-CMC), N-ethyl Pentedrone (NEP), and N-ethyl Hexedrone (NEH, also named HEXEN) in oral fluid and sweat and verifies its feasibility in determining human oral fluid concentrations and pharmacokinetics following the administration of 100 mg of 4-CMC orally and 30 mg of NEP and NEH intranasally. A total of 48 oral fluid and 12 sweat samples were collected from six consumers. After the addition of 5 μL of methylone-d
3 and 200 μL of 0.5 M ammonium hydrogen carbonate, an L/L extraction was carried out using ethyl acetate. The samples, dried under a nitrogen flow, were then derivatized with pentafluoropropionic anhydride and dried again. One microliter of the sample reconstituted in 50 μL of ethyl acetate was injected into GC-MS/MS. The method was fully validated according to international guidelines. Our results showed how, in oral fluid, the two cathinones taken intranasally were absorbed very rapidly, within the first hour, when compared with the 4-CMC which reached its maximum concentration peak in the first three hours. We observed that these cathinones were excreted in sweat in an amount equivalent to approximately 0.3% of the administered dose for 4-CMC and NEP. The total NEH excreted in sweat 4 h after administration was approximately 0.2% of the administered dose. Our results provide, for the first time, preliminary information about the disposition of these synthetic cathinones in the consumers' oral fluid and sweat after controlled administration.- Published
- 2023
- Full Text
- View/download PDF
36. Synthetic cannabinoids use in a sample of opioid-use disorder patients.
- Author
-
Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Farré M, and Torrens M
- Abstract
Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detected by the standard test used in the clinical practice and drug-checking is more common in recreational settings. A cross-sectional study with samples of 301 opioid use disorder individuals was carried out at the addiction care services from Barcelona and Badalona. Urinalysis was performed by high-sensitivity gas chromatography-mass spectrometry (GC-MS) and ultra-high-performance liquid chromatography-high -resolution mass spectrometry (UHPLC-HRMS). Any synthetic cannabinoid was detected in 4.3% of the individuals and in 23% of these samples two or more synthetic cannabinoids were detected. Among the 8 different synthetic cannabinoids detected, most common were JWH-032 and JWH-122. Natural cannabis was detected in the 18.6% of the samples and only in the 0.7% of them THC was identified. Several different synthetic cannabinoids were detected and a non-negligible percentage of natural cannabis was detected among our sample. Our results suggest that the use of synthetic cannabinoids may be related to the avoidance of detection. In the absence of methods for the detection of these substances in clinical practice, there are insufficient data and knowledge making difficult to understand about this phenomenon among opioid use disorder population., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Alías-Ferri, Pellegrini, Marchei, Pacifici, Rotolo, Pichini, Pérez-Mañá, Papaseit, Muga, Fonseca, Farré and Torrens.)
- Published
- 2022
- Full Text
- View/download PDF
37. New Psychoactive Substances Consumption in Opioid-Use Disorder Patients.
- Author
-
Alías-Ferri M, Pellegrini M, Marchei E, Pacifici R, Rotolo MC, Pichini S, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Torrens M, and Farré M
- Abstract
(1) Background: Since the beginning of the 21st century, the large number and wide chemical variety of new psychoactive substances (NPS) that enter the market every year has become a public health problem. Given the rapidity with which the drug market is changing, many NPS are not clinically investigated and their effects and health risks are unknown. Drug testing is a very useful tool for this purpose, but, unfortunately, it is not very widespread in individuals with opioid-use disorder under detoxification treatment. The aim of this study is to investigate the use of illicit drugs and NPS in opioid-use disorder (OUD) patients on opioid agonist treatment. (2) Methods: A multicenter, descriptive, cross-sectional study was conducted at two addiction care services in Barcelona and Badalona, Spain. Urine samples were collected from OUD individuals attending these two centers, who anonymously donated a urine sample at the time of a periodical visit. Samples were analyzed by high-sensitivity gas chromatography-mass spectrometry (GC-MS) and ultra-high-performance liquid chromatography-high -resolution mass spectrometry (UHPLC-HRMS). (3) Results: Out of the 187 collected and analyzed urine samples, 27.3% were positive for any type of NPS and 8.6% were positive for new synthetic opioids, including fentanyl and its derivatives (NSO). Other frequently detected substances were benzodiazepines in 46.0% of samples, antipsychotics in 27.8% of samples, or cocaine and cannabis in 23.5% of samples. (4) Conclusion: A wide number of NPS, including NSO, have been detected in urine samples from an OUD population. A lack of NPS detection in standard drug screening among drug users can hide the identification of a potential public health problem.
- Published
- 2022
- Full Text
- View/download PDF
38. Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women.
- Author
-
Gómez-Ruiz LM, Marchei E, Rotolo MC, Brunetti P, Mannocchi G, Acosta-López A, Ramos-Gutiérrez RY, Varela-Busaka MB, Pichini S, and Garcia-Algar O
- Abstract
For the first time, the present study employed hair testing to investigate the prevalence of classical drugs of abuse and new psychoactive substances use during gestation in a cohort of 300 Mexican pregnant women. An interview was conducted to collect data on sociodemographic aspects of the patients, and a 9 cm-long hair strand was taken from the back of the head of each mother one month after delivery. A validated ultra-high-performance liquid chromatography−high-resolution mass spectrometry method was used for the screening of classic drugs, new psychoactive substances, and medications in maternal hair. Out of 300 examined hair samples from pregnant women, 127 (42.3%) resulted positive for psychoactive substances: 45 (35.4%) for cannabis only, 24 (18.9%) for methamphetamine only, 13 (10.2%) for cocaine only, 1 (0.3%) for heroin, 1 for N-N-dimethyltryptamine (0.3%), 1 for ketamine (0.8%), and 35 (16.3%) for more than one psychoactive substance. Furthermore, seven samples (2.3%) resulted positive for new psychoactive substances (NPS): two samples for synthetic cannabinoids, two for synthetic cathinones, and three for nor-fentanyl, and 3.3% of women hair resulted positive for anticonvulsant, antidepressant, and antipsychotic medications. Finally, 83 women hair samples (27.7%) tested positive for nicotine. Nonsteroidal anti-inflammatory drugs (NSAIDs) and other painkillers (60.0%), medications for the treatment of nausea and vomiting (12.3%), antihistamines (8.7%) and nasal/sinus decongestants (6.7%), cough suppressants (5.0%), and bronchodilator agents (5.0%) were also detected in pregnant women hair. The gestational use of psychoactive substances and exposure to tobacco smoke, assessed by hair testing, were associated with a significantly younger age and with a low education grade of the mothers (p < 0.005). This study provides a significant preliminary indication of the under-reported gestational consumption of licit and illicit psychoactive and pharmacologically active drugs in a Mexican environment, showing the value of toxicological and forensic analyses in the global effort to determine the health risks caused by classic drugs and new psychoactive substances during pregnancy.
- Published
- 2022
- Full Text
- View/download PDF
39. Assessment of licit and illicit drugs consumption during pregnancy by Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry (UHPLC-HRMS) target screening in Mexican women hair.
- Author
-
Marchei E, Rotolo MC, Mannocchi G, Capomassi A, Gómez-Ruiz LM, Acosta-López A, Ramos-Gutiérrez RY, Varela-Busaka MB, Pichini S, and García-Algar Ó
- Subjects
- Chromatography, High Pressure Liquid methods, Female, Hair chemistry, Humans, Mass Spectrometry, Pregnancy, Substance Abuse Detection methods, Illicit Drugs analysis, Substance-Related Disorders
- Abstract
Substance use in pregnancy is a global public health problem, both in developed and developing countries. Whereas information is available for major western countries, scarce data are present for the second ones. The objective assessment of pregnancy consumption of xenobiotic is provided by analysis of maternal hair, which can account for gestational consumption, given the possibility to analyze 9 cm hair corresponding to the pregnancy months. Here, we describe an ultra-high-performance liquid chromatography high-resolution mass spectrometry (UHPLC-HRMS) method used as screening analysis of classic drugs, new psychoactive substances and medications in hair from a cohort of pregnant Mexican women. The UHPLC-HRMS method included Accucore™ phenyl Hexyl (100 × 2.1 mm, 2.6 µm, Thermo, USA) column with a gradient mobile phase and a full-scan data-dependent MS2 (ddMS2) mode for substances identification (mass range 100-750 m/z). Results from the first 100 samples disclosed the presence of several undeclared and declared psychoactive substances and medications, being methamphetamine and paracetamol the most prevalent ones found in 20% and 43% cases, respectively. In addition, biomarkers of cannabis and tobacco use as well as those of antihistamines and antiemetic drugs were also prevalent. Albeit preliminary, these data confirm the feasibility of hair screening by UHPLC-HRMS to objectively assess xenobiotic consumption in pregnant women with consequent risk of fetal exposure to toxic substances., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
40. New Synthetic Opioids Use among Patients in Treatment for an Opioid Use Disorder in Barcelona.
- Author
-
Alías-Ferri M, Marchei E, Pacifici R, Pichini S, Pellegrini M, Pérez-Mañá C, Papaseit E, Muga R, Fonseca F, Farré M, and Torrens M
- Subjects
- Analgesics, Opioid therapeutic use, Cross-Sectional Studies, Female, Fentanyl, Humans, Male, Middle Aged, Drug Overdose, Opioid-Related Disorders drug therapy, Opioid-Related Disorders epidemiology
- Abstract
Introduction: New synthetic opioids (NSO), a class of new psychoactive substances (NPS), have recently emerged and pose an upcoming global public health challenge. The effects produced by NSO are similar to those from morphine, but they present greater pharmacological potency and abuse potential. Due to the increasing number of fatal overdoses and seizures in which NSO have been detected as heroin substitutes or adulterants, individuals with Opioid Use Disorder (OUD) represent a vulnerable population. The aim of our study was to describe and characterize from a gender perspective a Spanish cohort of potential conscious or unconscious NSO users., Methods: A cross-sectional study was conducted in a cohort of OUD participants under treatment in addiction care services in Barcelona and Badalona, Spain. Clinical evaluation was performed through an ad hoc survey, a scale to evaluate reasons to use an opioid without prescription (range 0-4) and the Wellbeing Index (WHO-5) (range 0-100). Objective consumption of NSO was assessed by urinalysis carried out by two validated methods: high-sensitivity gas chromatography-mass spectrometry (MS) and ultra-high-performance liquid chromatography-high-resolution MS., Results: A total of 154 participants with OUD were enrolled. They were mainly men (72.7%), mean age 47.8 years. Methadone was the predominant medication for opioid agonist treatment (mean dose 61.25 mg/day). A total of 32 (20.8%) participants reported having consumed some opioid to become "high" in the previous 3 months. The principal reasons for consuming illicit opioids were Replacing other drugs (mean 2.03) and Availability (mean 1.62), although Low price, was more highly valued by men (p = 0.045) and Shorter effect duration, most highly rated by women (p = <0.001). In the WHO-5, the mean score was 55 (SD = 30.1) without differences by gender. Fentanyl and derivatives or/and metabolites were detected in 7 (6.1%) participants, but illicit/non-prescribed NSOs were found in 5 out of 114 patients (4.4%), and other non-fentanyl opioids in 36 participants (26 men and 10 women)., Conclusion: A non-negligible consumption of NSO-fentanyl's (positive detection in 6.1% of biological samples) was detected. The reasons for using these substances and also the well-being differed between the genders. There is therefore both voluntary and involuntary NSO consumption in our country which highlights the importance of approaching this potential public health problem., (© 2022 The Author(s). Published by S. Karger AG, Basel.)
- Published
- 2022
- Full Text
- View/download PDF
41. Clinical features and risk factors associated with prenatal exposure to drugs of abuse.
- Author
-
Roca A, Jarque P, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Subjects
- Aged, Humans, Infant, Newborn, Pregnancy, Meconium, Risk Factors, Female, Cannabis, Pharmaceutical Preparations, Prenatal Exposure Delayed Effects epidemiology
- Abstract
Introduction: Early identification of neonates exposed to drugs of abuse during pregnancy allows a more precise clinical management., Objectives: To describe the clinical characteristics and to identify risk factors associated with the early detection of neonates exposed to drugs of abuse in a Neonatal Intermediate and Intensive Care Unit., Methods: Prospective observational study of neonates with and without clinical suspicion of prenatal exposure to drugs of abuse. Meconium was analyzed using standard chromatographic techniques. Univariate and multivariate statistical analyzes were performed., Results: 372 neonates were included. Exposure to drugs of abuse was detected in 49 (13.2%) cases: in 41 (83.7%) one drug and in 8 (16.3%) more than one. Somatometry at birth revealed: a) lower length percentile in those exposed to some drug, more than one and cannabis; b) lower weight percentile in those exposed to cannabis and of these compared to those exposed to alcohol. In neonates older than 34 pregnancy weeks (PW): a) lower length percentile in those exposed to any substance; b) lower percentile of length and weight in exposed to more than one. The most clinically relevant independent risk factors useful to detect cases of prenatal exposure to drugs of abuse were (Odds ratio (95% CI)): reason for admission other than prematurity (5.52 (2.55-1.93)), length percentile less than 33 (1.95 (1.05-3.60) and 2.14 (1.04-3.40) in older than 34 PW) and social dystocia/uncontrolled pregnancy in older than 34 PW (4.47 (1.03-19.29))., Conclusions: There are somatometric alterations and risk factors that can help in the early detection of neonates exposed to drugs of abuse. The somatometric alterations identified can be useful to extend the differential diagnosis of these alterations and to study their causes., (Copyright © 2021 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
42. Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers.
- Author
-
Marchei E, Ferri MA, Torrens M, Farré M, Pacifici R, Pichini S, and Pellegrini M
- Subjects
- Analgesics, Opioid urine, Chromatography, High Pressure Liquid, Humans, Methadone urine, Substance-Related Disorders urine, Gas Chromatography-Mass Spectrometry, Psychotropic Drugs urine
- Abstract
The use of the new psychoactive substances is continuously growing and the implementation of accurate and sensible analysis in biological matrices of users is relevant and fundamental for clinical and forensic purposes. Two different analytical technologies, high-sensitivity gas chromatography-mass spectrometry (GC-MS) and ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) were used for a screening analysis of classic drugs and new psychoactive substances and their metabolites in urine of formed heroin addicts under methadone maintenance therapy. Sample preparation involved a liquid-liquid extraction. The UHPLC-HRMS method included Accucore™ phenyl Hexyl (100 × 2.1 mm, 2.6 μm, Thermo, USA) column with a gradient mobile phase consisting of mobile phase A (ammonium formate 2 mM in water, 0.1% formic acid) and mobile phase B (ammonium formate 2 mM in methanol/acetonitrile 50:50 ( v / v ), 0.1% formic acid) and a full-scan data-dependent MS2 (ddMS2) mode for substances identification (mass range 100-1000 m / z ). The GC-MS method employed an ultra-Inert Intuvo GC column (HP-5MS UI, 30 m, 250 µm i.d, film thickness 0.25 µm; Agilent Technologies, Santa Clara, CA, USA) and electron-impact (EI) mass spectra were recorded in total ion monitoring mode (scan range 40-550 m / z ). Urine samples from 296 patients with a history of opioid use disorder were examined. Around 80 different psychoactive substances and/or metabolites were identified, being methadone and metabolites the most prevalent ones. The possibility to screen for a huge number of psychotropic substances can be useful in suspected drug related fatalities or acute intoxication/exposure occurring in emergency departments and drug addiction services.
- Published
- 2021
- Full Text
- View/download PDF
43. Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants.
- Author
-
Jarque P, Roca A, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Abstract
Background: The accurate assessment of fetal exposure to psychoactive substances provides the basis for appropriate clinical care of neonates. The objective of this study was to identify maternal socio-demographic profiles and risk factors for prenatal exposure to drugs of abuse by measuring biomarkers in neonatal matrices., Methods: A prospective, observational cohort study was completed. Biomarkers of fetal exposure were measured in meconium samples. The mothers were interviewed using a questionnaire. Univariate and multivariate logistic regression analyses were performed., Results: A total of 372 mothers were included, 49 (13.2%) testing positive for psychoactive substances use: 24 (49.0%) for cannabis, 11 (22.5%) for ethyl glucuronide, six (12.2%) for cocaine, and in eight (16.3%) more than one psychoactive substance. Mothers who consumed any psychoactive substance (29.7 ± 6.6 years) or cannabis (27.0 ± 5.7 years) were younger than non-users (32.8 ± 6.2 years, p < 0.05). Cocaine (50.0% vs. 96.9%, p < 0.05) and polydrug users (37.5% vs. 96.9%, p < 0.05) showed a lower levels of pregnancy care. Previous abortions were associated with the use of two or more psychoactive substances (87.5% vs. 37.8%, p < 0.05). Single-mother families (14.3% vs. 2.5%, p < 0.05) and mothers with primary level education (75.5% vs. 55.1%, p < 0.05) presented a higher consumption of psychoactive substances. Independent risk factors that are associated with prenatal exposure include: maternal age < 24 years (odds ratio: 2.56; 95% CI: 1.12-5.87), lack of pregnancy care (odds ratio: 7.27; 95%CI: 2.51-21.02), single-mother families (odds ratio: 4.98; 95%CI: 1.37-8.13), and active tobacco smoking (odds ratio: 8.13; 95%CI: 4.03-16.43)., Conclusions: These results will allow us to develop several risk-based drug screening approaches to improve the early detection of exposed neonates.
- Published
- 2021
- Full Text
- View/download PDF
44. Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS.
- Author
-
La Maida N, Pellegrini M, Papaseit E, Pérez-Mañá C, Poyatos L, Ventura M, Galindo L, Busardò FP, Pichini S, Farré M, and Marchei E
- Subjects
- Adult, Cannabinoids administration & dosage, Cannabinoids analysis, Chromatography, Liquid, Female, Humans, Indoles administration & dosage, Indoles analysis, Male, Marijuana Smoking metabolism, Mass Spectrometry, Mouth Mucosa metabolism, Naphthalenes administration & dosage, Naphthalenes analysis, Saliva chemistry, Cannabinoids pharmacokinetics, Indoles pharmacokinetics, Naphthalenes pharmacokinetics, Saliva metabolism
- Abstract
The consumption of synthetic cannabinoids (SCs) has significantly increased in the last decade and the analysis of SCs and their metabolites in human specimens is gaining interest in clinical and forensic toxicology. A pilot study has been carried out using a combination of an initial last generation gas chromatography-mass spectrometry (GC-MS) screening method for the determination of JWH-122, JWH-210, UR-144) in oral fluid (OF) of consumers and an ultra-high performance liquid chromatography high resolution mass spectrometry (UHPLC-HRMS) confirmatory method for the quantification of the parent compounds and their metabolites in the same biological matrix. OF samples were simply liquid-liquid extracted before injecting in both chromatographic systems. The developed methods have been successfully validated and were linear from limit of quantification (LOQ) to 50 ng/mL OF. Recovery of analytes was always higher than 70% and matrix effect always lower than 15% whereas intra-assay and inter-assay precision and accuracy were always better than 16%. After smoking 1 mg JWH-122 or UR-144 and 3 mg JWH-210, maximum concentration of 4.00-3.14 ng/mL JWH-122, 8.10-7.30 ng/mL JWH-210 ng/mL and 7.40 and 6.81 ng/mL UR-144 were measured by GC-MS and UHPLC-HRMS respectively at 20 min after inhalation. Metabolites of JWH 122 and 210 were quantified in OF by UHPLC-HRMS, while that of UR144 was only detectable in traces. Our results provide for the first time information about disposition of these SCs and their metabolites in consumers OF. Last generation GC-MS has proven useful tool to identify and quantify parent SCs whereas UHPLC-HRMS also confirmed the presence of SCs metabolites in the OF of SCs consumers.
- Published
- 2020
- Full Text
- View/download PDF
45. [Clinical features and risk factors associated with prenatal exposure to drugs of abuse].
- Author
-
Roca A, Jarque P, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Abstract
Introduction: Early identification of neonates exposed to drugs of abuse during pregnancy allows a more precise clinical management., Objectives: To describe the clinical characteristics and to identify risk factors associated with the early detection of neonates exposed to drugs of abuse in a Neonatal Intermediate and Intensive Care Unit., Methods: Prospective observational study of neonates with and without clinical suspicion of prenatal exposure to drugs of abuse. Meconium was analyzed using standard chromatographic techniques. Univariate and multivariate statistical analyzes were performed., Results: 372 neonates were included. Exposure to drugs of abuse was detected in 49 (13.2%) cases: in 41 (83.7%) one drug and in 8 (16.3%) more than one. Somatometry at birth revealed: a) lower length percentile in those exposed to some drug, more than one and cannabis; b) lower weight percentile in those exposed to cannabis and of these compared to those exposed to alcohol. In neonates older than 34 pregnancy weeks (PW): a) lower length percentile in those exposed to any substance; b) lower percentile of length and weight in exposed to more than one. The most clinically relevant independent risk factors useful to detect cases of prenatal exposure to drugs of abuse were (Odds ratio (95% CI)): reason for admission other than prematurity (5.52 (2.55-1.93)), length percentile less than 33 (1.95 (1.05-3.60) and 2.14 (1.04-3.40) in older than 34 PW) and social dystocia/uncontrolled pregnancy in older than 34 PW (4.47 (1.03-19.29))., Conclusions: There are somatometric alterations and risk factors that can help in the early detection of neonates exposed to drugs of abuse. The somatometric alterations identified can be useful to extend the differential diagnosis of these alterations and to study their causes., (Copyright © 2020. Publicado por Elsevier España, S.L.U.)
- Published
- 2020
- Full Text
- View/download PDF
46. UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers.
- Author
-
Pellegrini M, Marchei E, Papaseit E, Farré M, and Zaami S
- Subjects
- Humans, Reproducibility of Results, Chromatography, High Pressure Liquid methods, Gas Chromatography-Mass Spectrometry methods, Illicit Drugs urine, Indoles urine, Naphthalenes urine
- Abstract
Background and Objectives : The use of synthetic cannabinoids has increased around the world. As a result, the implementation of accurate analysis in human biological matrices is relevant and fundamental. Two different analytical technologies, ultra-high-performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) and high-sensitivity gas chromatography-mass spectrometry (GC-MS) were used for the determination of three synthetic cannabinoids JWH-122, JWH 210, UR-144 and their metabolites in urine of consumers. Materials and Methods : Sample preparation included an initial hydrolysis with β-glucuronidase and liquid-liquid extraction. The UHPLC-HRMS method included a Kinetex 2.6 u Biphenyl 100A (100 × 2.1 mm, 2.6 μm) (Phenomenex, Italy) column with a gradient mobile phase consisting of mobile phase A (ammonium formate 2mM in water, 0.1% formic acid) and mobile phase B (ammonium formate 2mM in methanol/acetonitrile 50:50 (v/v), 0.1% formic acid) and a full-scan data-dependent MS2 (ddMS2) mode was used (mass range 100-1000 m/z). The GC-MS method employed an ultra-Inert Intuvo GC column (HP-5MS UI, 30 m × 250 µm i.d, film thickness 0.25 µm; Agilent Technologies, Santa Clara, CA, USA) and electron-impact (EI) mass spectra were recorded in total ion monitoring mode (scan range 40-550 m/z). Results: Both methods have been successfully used for screening of parent synthetic cannabinoids and their metabolites in urine samples of consumers. Conclusions: The screening method applied JWH-122, JWH-210, UR-144 and their metabolites in urine of consumers can be applied to other compounds of the JWH family.
- Published
- 2020
- Full Text
- View/download PDF
47. Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid.
- Author
-
Marchei E, Malaca S, Graziano S, Gottardi M, Pichini S, and Busardò FP
- Subjects
- Amphetamine, Cocaine analogs & derivatives, Codeine, Illicit Drugs, Methamphetamine analogs & derivatives, Morphine, Morphine Derivatives, N-Methyl-3,4-methylenedioxyamphetamine, Specimen Handling, Drug Stability, Forensic Toxicology, Psychotropic Drugs chemistry, Substance Abuse Detection
- Abstract
Sampling and drug stability in oral fluid (OF) are crucial factors when interpreting forensic toxicological analysis, mainly because samples may not be analyzed immediately after collection, potentially altering drug concentrations. Therefore, the stability of some common drugs of abuse (morphine, codeine, 6-monoacetylmorphine, cocaine, benzoylecgonine, Δ9-tetrahydrocannabinol, cannabidiol, amphetamine, 3,4-methylenedioxymethamphetamine, ketamine) and the more commonly consumed new psychoactive substances in our environment (mephedrone, and N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 5F-AKB48 also known as 5F-APINACA) was investigated in an OF pool for the presence and absence of M3 Reagent Buffer® up to 1 year of storage. Fortified OF samples were stored at three different temperatures (room temperature, 4 and -20°C) to determine the best storage conditions over time. Control fortified OF samples were stored at -80°C for reference purposes. Compounds with concentration changes within ±15% of initial value were considered stable. The drugs were significantly more stable in M3 Reagent Buffer® than in neat OF samples in all storage conditions. All analytes were stable for 1 year at 4°C and -20°C in M3 Reagent Buffer®. Drugs stability in OF varied depending on the analyte, the presence of a stabilizer, the storage duration and temperature. When immediate sample analysis is not possible, we suggest to store OF samples at 4 or -20°C and test them within 2 weeks. Alternatively, OF samples may be stored at 4 or -20°C with M3 Reagent Buffer® to be tested within 1 year., (© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
48. Is "light cannabis" really light? Determination of cannabinoids content in commercial products.
- Author
-
Marchei E, Tittarelli R, Pellegrini M, Rotolo MC, Pacifici R, and Pichini S
- Subjects
- Chromatography, High Pressure Liquid, Europe, Gas Chromatography-Mass Spectrometry, Tandem Mass Spectrometry, Cannabinoids chemistry, Cannabis chemistry
- Published
- 2020
- Full Text
- View/download PDF
49. Novel fast ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) and extraction of ethylglucuronide in meconium samples.
- Author
-
Malaca S, Marchei E, Barceló Martín B, Minutillo A, and Pichini S
- Subjects
- Chromatography, High Pressure Liquid economics, Glucuronates isolation & purification, Humans, Infant, Newborn, Limit of Detection, Solid Phase Extraction economics, Solid Phase Extraction methods, Tandem Mass Spectrometry economics, Time Factors, Chromatography, High Pressure Liquid methods, Glucuronates analysis, Meconium chemistry, Tandem Mass Spectrometry methods
- Published
- 2019
- Full Text
- View/download PDF
50. Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry.
- Author
-
Pacifici R, Marchei E, Salvatore F, Guandalini L, Busardò FP, and Pichini S
- Subjects
- Cannabis metabolism, Drug Stability, Flowering Tops chemistry, Flowering Tops metabolism, Light, Temperature, Time Factors, Cannabinoids analysis, Cannabis chemistry, Chromatography, High Pressure Liquid, Plant Oils chemistry, Tandem Mass Spectrometry
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.